Peloton Therapeutics Inc - Company Review
Peloton Therapeutics Inc - Company ReviewSummary
Peloton Therapeutics Inc (Peloton) is a clinical-stage biotechnology company with a focus on developing novel therapies targeting renal and other cancers. The company's lead product, PT2385, is a first-in-class small molecule targeting hypoxia inducible factor-2-alpha (HIF-2 alpha) for the development and progression of advanced clear cell renal cell carcinomas (ccRCC) and other oncology indications such as glioblastoma, von Hippel-Lindau disease (VHL). Peloton’s pipeline products also comprise small molecule programs designed for indications such as oncology, immuno-oncology, solid tumors and pulmonary arterial hypertension. It works in partnership with academic and research institutions, pharmaceutical, biotechnology companies for the development and commercialization of new medicines. The company is funded by venture capital firms such as The Column Group, Remeditex Ventures, LLC, Nextech Invest LTD, Tichenor Ventures, LLC. Peloton is headquartered in Dallas, Texas, the US.
This comprehensive company report of Peloton Therapeutics Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.